VRDN - CIK 0001590750
Viridian Therapeutics, Inc.DE has filed 794 documents with the SEC between 2013 and 2026. The most frequent type is insider trade (199 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Prospectus supplement | 424B5 | 2025-10-23 | - |
| Prospectus supplement | 424B5 | 2025-10-21 | - |
| Major company event | 8-K | 2025-10-21 | 2025-10-21 |
| Major company event | 8-K | 2025-10-20 | 2025-10-17 |
| S-3ASR | - | 2025-09-05 | - |
| Quarterly report | 10-Q | 2025-08-06 | 2025-06-30 |
| Employee stock plan | S-8 | 2025-08-06 | - |
| Major company event | 8-K | 2025-08-06 | 2025-08-06 |
| Major company event | 8-K | 2025-07-30 | 2025-07-30 |
| Insider trade | 4 | 2025-07-02 | 2025-07-01 |
| Insider trade | 4 | 2025-07-02 | 2025-07-01 |
| Insider trade | 4 | 2025-07-02 | 2025-07-01 |
| Insider trade | 4 | 2025-07-02 | 2025-07-01 |
| Insider trade | 4 | 2025-07-02 | 2025-07-01 |
| Insider trade | 4 | 2025-07-02 | 2025-07-01 |
| Major company event | 8-K | 2025-06-24 | 2025-06-20 |
| Insider trade | 4 | 2025-06-11 | 2025-06-09 |
| Major company event | 8-K | 2025-05-20 | 2025-05-20 |
| SCHEDULE 13G | - | 2025-05-15 | - |
| Quarterly report | 10-Q | 2025-05-06 | 2025-03-31 |
| Major company event | 8-K | 2025-05-06 | 2025-05-06 |
| Annual report to shareholders | ARS | 2025-04-25 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-25 | - |
| Proxy statement | DEF 14A | 2025-04-25 | 2025-06-20 |
| SCHEDULE 13G | - | 2025-04-11 | - |
| Insider trade | 4 | 2025-04-09 | 2025-04-07 |
| New insider ownership | 3 | 2025-04-09 | 2025-04-07 |
| Major company event | 8-K | 2025-04-07 | 2025-04-02 |
| Insider trade | 4 | 2025-03-12 | 2025-03-10 |
| New insider ownership | 3 | 2025-03-12 | 2025-03-10 |
| Insider trade | 4 | 2025-03-12 | 2025-03-10 |
| New insider ownership | 3 | 2025-03-12 | 2025-03-10 |
| Major company event | 8-K | 2025-03-10 | 2025-03-05 |
| Major company event | 8-K | 2025-03-04 | 2025-03-03 |
| Prospectus supplement | 424B5 | 2025-03-04 | - |
| Insider trade | 4 | 2025-03-04 | 2025-03-03 |
| Insider trade | 4 | 2025-03-04 | 2025-03-03 |
| Insider trade | 4 | 2025-03-04 | 2025-03-03 |
| Insider trade | 4 | 2025-03-04 | 2025-03-03 |
| Annual report | 10-K | 2025-03-03 | 2024-12-31 |
| Employee stock plan | S-8 | 2025-03-03 | - |
| Major company event | 8-K | 2025-02-27 | 2025-02-27 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| Major company event | 8-K | 2025-01-10 | 2025-01-07 |
| Major company event | 8-K | 2024-12-16 | 2024-12-16 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Quarterly report | 10-Q | 2024-11-12 | 2024-09-30 |